Evaluation of HDL Subfraction Changes and HDL-Associated Enzymes in Liver Failure Patients and Healthy Donors

NCT05958420 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2023-07-24

No results posted yet for this study

Summary

This study aimed to determine high-density lipoprotein (HDL) subfraction profile and HDL-associated enzyme changes in liver failure patients and healthy donors.

Conditions

  • Liver Failure

Sponsors & Collaborators

  • Akdeniz University

    lead OTHER

Principal Investigators

  • İlker O Aycan · Akdeniz University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2022-01-15
Completion
2022-01-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05958420 on ClinicalTrials.gov